Showing results (1-10 of 90) with videos related to
Sort By:
Pageof 9
Annual Review of Medicine|November 7, 2017
Targeting RAGE Signaling in Inflammatory DiseaseBarry I Hudson, Marc E LippmanPsychosomatic Medicine|August 18, 2022
Relationships Between Serum Cortisol, RAGE-Associated s100A8/A9 Levels, and Self-Reported Cancer-Related Distress in Women With Nonmetastatic Breast CancerChloe J Taub, Alain Diaz, Bonnie B Blomberg, et al.NPJ Breast Cancer|July 13, 2023
RAGE inhibitor TTP488 (Azeliragon) suppresses metastasis in triple-negative breast cancerMelinda Magna, Gyong Ha Hwang, Alec McIntosh, et al.Breast Cancer Research and Treatment|March 5, 2004
Evaluation of novel epidermal growth factor receptor tyrosine kinase inhibitorsJames M Rae, Marc E LippmanThe Journal of Clinical Investigation|December 15, 2021
The role of estrogen receptor signaling in suppressing the immune response to cancerJames M Rae, Marc E LippmanPharmaceutical Research|August 5, 2004
RAGE: a novel target for drug intervention in diabetic vascular diseaseBarry I Hudson, Ann Marie SchmidtSeminars in Oncology|November 13, 2003
Targeting Bcl-2 and Bcl-XL with nonpeptidic small-molecule antagonistsShaomeng Wang, Dajun Yang, Marc E LippmanCancer|January 12, 2019
The effects of a randomized trial of brief forms of stress management on RAGE-associated S100A8/A9 in patients with breast cancer undergoing primary treatmentChloe J Taub, Marc E Lippman, Barry I Hudson, et al.Plos One|November 22, 2013
Alternative splicing of the RAGE cytoplasmic domain regulates cell signaling and functionJoel Jules, Dony Maiguel, Barry I HudsonArthritis Research & Therapy|July 1, 2005
Soluble RAGE: a hot new biomarker for the hot joint?Bernhard Moser, Barry I Hudson, Ann Marie SchmidtPageof 9